Reducing oral steroid intolerability and drug costs for acute wheezers: a retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department.
Gail Lindsey DavisonJ RuddellM TroutonR McDonaldB KennedyVikki O'NeillJ McCannB BartholomeH SteenMichael D ShieldsS MullenPublished in: Pediatric pulmonology (2023)
Reduced intolerability and substantial cost savings can be achieved by implementing a structured acute pediatric wheeze algorithm and modifying the OCS to single-dose dexamethasone (300 mcg/kg). This article is protected by copyright. All rights reserved.